BNTX

An outside panel of experts for the Centers for Disease Control and Prevention on Thursday is scheduled to weigh whether children ages 5 to 11 should receive the newly authorized Covid-19…

U.S. health regulators cleared for use a booster shot of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE for children 5 to…

The Food and Drug Administration limited the use of the Covid-19 vaccine from Johnson and Johnson after reviewing the risk of life-threatening blood clots.The…

Pfizer Inc. PFE 2.79% expects demand for its Covid-19 antiviral drug to increase as governments return to replenish their supplies and…

Moderna Inc. has asked U.S. health regulators to authorize the use of its Covid-19 vaccine in children ages 6 months to 5 years old.The company said Thursday…

Moderna Inc. said it will never use its Covid-19 vaccine-related patents to stop others from manufacturing its vaccine in more than 90 low- and middle-income…

This story originally appeared on Zacks BioNTech SE Sponsored ADR (BNTX) closed the most recent trading day at $150.81, moving +0.13% from the previous trading…

The drugmakers said Tuesday they began enrolling adults ages 18 to 55 in the U.S. and South Africa to examine the safety, tolerability and immune response generated by the vaccine if it is…

U.S. health regulators cleared use of a Covid-19 booster from Pfizer Inc. PFE -4.05% and BioNTech SE…

A high-stakes legal battle is taking shape over lucrative patent rights for Covid-19 vaccines, with drug companies pitted against each other and government and academic scientists over who…